Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label progression free survival. Show all posts
Showing posts with label progression free survival. Show all posts
Sunday, May 27, 2012

Time to Ovarian Cancer Return Not Tied to BMI - in Meeting Coverage, ASCO from MedPage Today

›
Medical News: Time to Ovarian Cancer Return Not Tied to BMI - in Meeting Coverage, ASCO from MedPage Today Action Points Note that ...
Tuesday, April 10, 2012

abstract: A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer

›
 Blogger's Note: this is and has been an ongoing issue in clinical trials as most use still use overall survival (OS) ( as per this pap...
Thursday, March 08, 2012

open access: Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials (study included various cancers including ovarian cancer) note: patient warning before reading

›
Blogger's Note: patient warning - this is not a 'good news' paper so caution advised Table I   Patient Diagnoses, Gender, Med...
Saturday, February 18, 2012

updated - link to full free paper: Review: Therapeutic strategies in epithelial ovarian cancer (references clear cell ovarian)

›
 Blogger's Note: numerous references to clear cell ovarian cancer as per Japanese historical ovarian cancer research direct link to...
Wednesday, February 01, 2012

open access: 2011 Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective | Dr A. Oza | Current Oncology (topics: eg chronic disease, 1st line therapy...)

›
Blogger's Note: may require registration (free); note also list of useful (international) reference papers                           ...
Tuesday, January 03, 2012

Identifying Clinical Improvement in Consolidation Single-Arm Phase 2 Trials in Patients With Ovarian Cancer in Second or Greater Clinical Remission

›
Abstract Objective: Estimates of progression-free survival (PFS) from single-arm phase 2 consolidation/maintenance ...

Correction: ABCB1 (MDR1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy

›
link to original article: The authors of this article (Clin Cancer Res 2008;14:5594-601) , which was published in the September 1, 2008, i...
Thursday, December 29, 2011

A systematic review evaluating the relationship between Progression free survival and Post Progression survival in advanced ovarian cancer

›
Friday, May 13, 2011

abstract: Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study.

›
OBJECTIVES: To evaluate in a large phase III recurrent ovarian cancer trial (OVA-301): 1) the concordance between CA-125 level vs. bes...
Wednesday, April 06, 2011

Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerations

›
Abstract The purpose of this study was to investigate retrospectively the mRNA expression of genes involved in different DNA repair pathw...
Tuesday, June 08, 2010

detailed ASCO article: Bevacizumab Prolongs Progression-free Survival for Women with Advanced Ovarian Cancers - ASCO (includes chart)

›
Monday, June 07, 2010

ASCO: Debulking Predicts Survival in Recurrent Ovarian Cancer - in Meeting Coverage, ASCO

›
  "Our analysis represents the first study investigating the relevance of primary surgical outcome for survival after recurrence in ov...